BioCentury
ARTICLE | Company News

Ranbaxy sales and marketing update

October 15, 2012 7:00 AM UTC

Ranbaxy's Ranbaxy Pharmaceuticals Inc. subsidiary launched authorized generic cevimeline in the U.S. to treat symptoms of dry mouth associated with Sjogren's syndrome. Sjogren's syndrome is an autoimmune disorder affecting moisture producing glands. ...